Metraipolis › archive › dc_ca59a2ecea97
A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC… — Europe PMC PMID:41827675
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41827675
- DOI
- 10.3390/cancers18050740
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T12:16:11.923Z
- SHA-256 of the archived text
727a5704a926218f65d9d0756709dc48eb943f63fd55ab550104b19dd938bd37- Stable URL of this page
https://metraipolis.com/documento/dc_ca59a2ecea97
How to cite
A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC… — Europe PMC PMID:41827675 — Europe PMC (en), https://europepmc.org/article/MED/41827675 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca59a2ecea97 (Metraipolis archive dc_ca59a2ecea97, sha256 727a5704a926218f65d9d0756709dc48eb943f63fd55ab550104b19dd938bd37)
BibTeX
@misc{dcca59a2ecea97,
title = {A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC… — Europe PMC PMID:41827675},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41827675},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca59a2ecea97; sha256 727a5704a926218f65d9d0756709dc48eb943f63fd55ab550104b19dd938bd37},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41827675. Agents can read the archived copy with the MCP tool read_document.